Opinion Factsheet  

Farmaceutska strategija za Europu i zakonodavni prijedlog za promjenu mandata Europske agencije za lijekove (EMA)

Opinion Number: CDR 5525/2020
Rapporteur: SACRÉDEUS Birgitta
Commission: NAT
Status: Currently in discussion
Date: 07/05/2021
to draw attention to the critical role played by the local and regional levels in countries' crisis preparedness and to the need to involve them in framing measures to strengthen security of supply of medicines and reduce vulnerability
to consider the objectives and the flagship initiatives of the pharmaceutical strategy from the local/regional point of view as the healthcare systems are decentralised to varying degrees in 19 of the 27 Member States and local and regional authorities are also involved in funding healthcare in many Member States
to ensure that the legal framework for the future European Health Union recognises local and regional authorities' responsibility for public health and builds on lessons learned from crises at the levels of governance closest to ordinary people
to consider whether the practical facilities are there for Member States to provide the EMA with the information requested, and whether the proposal creates excessive red tape for Member States and the healthcare system
The rapporteur took part in preparatory meetings together with Mr Geblewicz and Mr Ciambetti: on 19 January with the EESC rapporteur on health, Mr Vardakastanis and on 22 January with a group of health experts in a public consultation round organised in association with EUREGHA.

On 9 February, Ms Sacrédeus chaired the meeting of the CoR Interregional Group on Health and Well Being (EUREGHA) where the discussion topics and priorities for 2021 were decided. Among other topics, the rapporteur also mentioned the issue of accessibility and affordability of medicines, vaccines and preparedness.

On 2 March, Ms Sacrédeus chaired the meeting of the CoR Interregional Group on Health and Wellbeing where the upcoming CoR opinions on strengthening ECDC mandate and on Pharmaceutical Strategy and EMA were discussed.

On 23 March, the rapporteur spoke at an online conference "The role of regions and cities in supporting apprenticeships: upskilling and reskilling in the health sector", organised by the CoR and the European Commission. The event focused on the role of cities and regions in supporting apprenticeships in the health sector and explored local and regional initiatives for training, upskilling and reskilling health workers, taking into account the future skill needs of the sector.

On 29 March, the rapporteur participated at the EESC hearing on 'Building a European Health Union', at the invitation of Mr. Ioannis Vardakastanis, rapporteur of the EESC opinion.